Device recall · May 20, 2020
BD Alaris PCEA Administration Set recall
Why: The products have the potential to leak between the connection of the male luer and the yellow striped tubing. This leak may be observed while priming or during use. The most likely health consequence associated with a leak in an administration set would be inadequate pain control for the patient due to an under-infusion of medication.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
BD Alaris PCEA Administration Set, Microbore Tubing with Yellow Identification Stripe ASV, Catalog Number 30893-04 (OUS Only) - Product Usage: Microbore Tubing with Yellow Identification Stripe Anti-siphon Valve Use Aseptic Technique Set cannot be used for gravity infusion. 1. Connect PCA syringe to female luer on administration set. 2. Push on syringe plunger to prime set. 3. Refer to PCA module Directions for Use for complete loading and operating instructions. Notes: The set should be changed according to facility protocol or in accordance with currently recognized guidelines for IV therapy. Antisiphon sets cannot be primed by gravity.
- Lots / codes
Lot Numbers: 19016079 19036183 19045426 19045426 19115483 19115483
- Quantity
- 110,350
- Company
- Bd Switzerland Sarl, Eysins, N/A
- Distribution
- Worldwide distribution - US Nationwide Distribution and the countries of Canada, Belgium.
- Initiated
- April 9, 2020 · Voluntary: Firm initiated
- Classified
- May 13, 2020
- Reported
- May 20, 2020
- Ended
- November 2, 2020
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.